.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Covington
US Department of Justice
Novartis
Cantor Fitzgerald
Queensland Health
McKinsey
Johnson and Johnson
Baxter
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview

Deserpidine - Generic Drug Details

« Back to Dashboard

What are the generic sources for deserpidine and what is the scope of deserpidine freedom to operate?

Deserpidine
is the generic ingredient in seven branded drugs marketed by Abbvie, Abbott, and Watson Labs, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for deserpidine.

Summary for deserpidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AbbottENDURONYL FORTEdeserpidine; methyclothiazideTABLET;ORAL012775-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieORETICYL FORTEdeserpidine; hydrochlorothiazideTABLET;ORAL012148-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbottENDURONYLdeserpidine; methyclothiazideTABLET;ORAL012775-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieHARMONYLdeserpidineTABLET;ORAL010796-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMETHYCLOTHIAZIDE AND DESERPIDINEdeserpidine; methyclothiazideTABLET;ORAL088452-001Aug 10, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieORETICYL 50deserpidine; hydrochlorothiazideTABLET;ORAL012148-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMETHYCLOTHIAZIDE AND DESERPIDINEdeserpidine; methyclothiazideTABLET;ORAL088486-001Aug 10, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieORETICYL 25deserpidine; hydrochlorothiazideTABLET;ORAL012148-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieHARMONYLdeserpidineTABLET;ORAL010796-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Fuji
Chinese Patent Office
Novartis
Boehringer Ingelheim
Cantor Fitzgerald
Moodys
Baxter
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot